Experimental CAR T therapy targets tumor’s immune shield, not cancer cells directly

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the cells that protect them.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup